New patent for Ocuphire drug RYZUMVI

Copyright © DrugPatentWatch. Originally published at https://www.drugpatentwatch.com/blog/

Annual Drug Patent Expirations for RYZUMVI
Annual Drug Patent Expirations for RYZUMVI

Ryzumvi is a drug marketed by Ocuphire and is included in one NDA.

The generic ingredient in RYZUMVI is phentolamine mesylate. Additional details are available on the phentolamine mesylate profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Make Better Decisions with DrugPatentWatch

» Start Your Free Trial Today «

Copyright © DrugPatentWatch. Originally published at
DrugPatentWatch - Make Better Decisions
Scroll to Top